(via TheNewswire)

Vancouver, BC –TheNewswire –6th January., 2021 – Solarvest BioEnergy Inc. (“Solar vest”, or the“society“) (TSXV: SVS)announces that it has arranged the settlement of $ 73,500 of debts through the issuance of ordinary shares in the company, which the advisory and advisory service provider (the“creditor”). Under the debt settlement, the company would issue up to 525,000 common shares of the company (the shares”) at an assumed price of $ 0.14 per share to the company’s creditors.

The conclusion of the settlement requires the consent of the TSX Venture Exchange. All securities issued under the Settlement are subject to resale restrictions for a period of four months and one day in accordance with applicable securities laws.

About Solarvest:

Solarvest BioEnergy Inc. is an algae biotechnology company whose production platform provides it with an extremely flexible system with which numerous valuable products from organic omega-3 fatty acids to therapeutic proteins / active ingredients can be manufactured. The company has successfully demonstrated (press release dated March 16. 2015) the expression of BMP, a high quality therapeutic protein, recombinant viral antigens (immune stimulating proteins) and cecropins (antimicrobial peptide / protein). The company has launched a program to express CBD and THC to be produced in GMP fermentation facilities.

For more information please contact:

Gerri Greenham,Managing Director

Email: [email protected]

the TSX Venture Exchange has neither approved nor disapproved of the contents of this press release.

Neither TSX Venture Exchange nor its regulatory service provider (as this term is used in the guidelines of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

S.Statements in this press release may contain forward-looking statements that involve a number of risks and uncertainties. Actual events or results could differ materially from the company’s expectations and forecasts.

Copyright (c) 2021 TheNewswire – All rights reserved.

Copyright (c) 2021 TheNewswire – All rights reserved., Source Press releases